Guinan Lian

Statistics

Publications

Citations

127

H-Index

Active since

2015

Affiliations

AbbVie (United States)(Current)

South Texas Accelerated Research Therapeutics

Yale University

Guinan Lian is an author at AbbVie (United States) specializing in medicine, pharmacodynamics of anticancer drugs, and pharmacokinetics of anticancer drugs.

Publications per year

2015–2018

Publications

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors

Anthony W. Tolcher, Patricia LoRusso, Jennifer A. Arzt et al. · Cancer Chemotherapy and Pharmacology · 2015 · 66 citations

Medicine, Oncology, Pharmacokinetics +11

Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study

Anthony W. Tolcher, Patricia LoRusso, Jennifer A. Arzt et al. · Cancer Chemotherapy and Pharmacology · 2015 · 38 citations

Medicine, Pharmacokinetics, Pharmacology +10

Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial

Michael L. Maitland, Sarina A. Piha‐Paul, Gerald S. Falchook et al. · British Journal of Cancer · 2018 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16

1–3 of 3